Medical Devices: Page 166


  • Image attribution tooltip
    Jacob Bell
    Image attribution tooltip

    FDA approves Novocure device to treat rare lung cancer

    The marketing authorization on the strength of a single-arm study drew criticism, with one prominent physician calling it a "new low" for FDA.

    By May 28, 2019
  • Industry slams FDA idea to limit old 510(k) predicates

    Between 2015 and 2018, approximately 20% of 510(k) applications were cleared based on a predicate older than 10 years, according to FDA.

    By David Lim • May 24, 2019
  • Boston Scientific's Farapulse pulsed field ablation device. Explore the Trendlineâž”
    Image attribution tooltip
    Permission granted by Boston Scientific
    Image attribution tooltip
    Trendline

    New medical devices are reshaping the medtech industry

    From pulsed field ablation devices to glucose sensors and surgical robotics, new medical technologies are transforming patient care and how people manage their health.

    By MedTech Dive staff
  • Faulty platelet counts trigger Class I recall of Beckman Coulter devices

    FDA is aware of more than 2,000 U.S. laboratories that may be affected by the inaccurate platelet counting but, so far, the agency hasn't received any reports of serious adverse events.

    By May 24, 2019
  • Image attribution tooltip
    Getty Images
    Image attribution tooltip

    Quality failings spur FDA crackdown on 2 defibrillator businesses

    Inspectors identified the same problems in 2018 as two years prior, leading the agency to send warning letters.

    By May 24, 2019
  • Image attribution tooltip
    Medtronic
    Image attribution tooltip

    Medtronic posts flat Q4, but beats Wall Street expectations

    Low-risk TAVR data and adoption of Mazor robotics systems were positives for the medtech giant. But tariffs, a sterilization disruption, safety concerns around drug-coated balloons and competition in diabetes created headwinds.

    By Maria Rachal • May 23, 2019
  • Edwards presents 6-month data on Pascal, eyeing MitraClip

    The structural heart giant's CE-marked system showed sustained mitral regurgitation improvement in patients. The company is gearing up for a head-to-head trial against Abbott's device, which is the only FDA-approved option.

    By Maria Rachal • May 23, 2019
  • Anti-Kickback Statute safe harbor revisions set for July

    The newly released Spring 2019 Unified Agenda lays out government plans to align domestic and international medical device quality systems, define which types of software are considered devices, and more.

    By David Lim • May 23, 2019
  • Image attribution tooltip
    Getty Images
    Image attribution tooltip

    FDA wants new companies to help test its Pre-Cert Program

    One pilot company's CEO told MedTech Dive FDA's search for new companies "is not a surprise to us" and "is a really good thing for the Pre-Cert program."

    By David Lim • May 23, 2019
  • LifeScan deal challenges Abbott, Dexcom for CGM market

    The former Johnson & Johnson unit has teamed with Sanvita Medical to sell continuous glucose monitor systems in North America and some European countries beginning in 2020.

    By May 23, 2019
  • Medtronic results build case for renal denervation device

    One study linked Symplicity to a reduced occurrence of subclinical atrial fibrillation in a subset of high-risk patients.

    By May 23, 2019
  • FDA on Abiomed right heart device: patient selection is key

    In its latest update on the safety of Impella RP, FDA said Monday the most recent post-approval study results for the device show comparable survival outcomes among patients who would have qualified for premarket studies.

    By Updated Dec. 3, 2019
  • Abbott releases 30-day data on tricuspid valve repair system

    The late-breaking study results released at the EuroPCR meeting in Paris showed the investigational device reduced tricuspid regurgitation at 30 days.

    By May 22, 2019
  • Biotronik stent bests Medtronic in study of small-vessel lesions

    Evidence from a sub-group analysis of a three-year clinical trial supports the theory that stents with very thin struts are less likely to require repeat revascularization in patients.

    By May 22, 2019
  • Image attribution tooltip
    Jacob Bell
    Image attribution tooltip

    Integra LifeSciences recall draws Class I label from FDA

    The New Jersey-based device maker began recalling 42,100 cerebrospinal fluid drainage systems after receiving complaints about broken stopcocks.

    By May 22, 2019
  • The FDA logo on a glass pane at the agency's campus in Silver Spring, Maryland.
    Image attribution tooltip
    Jacob Bell/MedTech Dive
    Image attribution tooltip

    Stryker wins approval for brain aneurysm stent system

    The product, designed to treat wide-neck intracranial aneurysms, adds to the company's rapidly growing neurovascular portfolio.

    By May 21, 2019
  • J&J's Auris unveils early results on Monarch robot for lung procedures

    The FDA-cleared robotic platform successfully localized lung nodules in 92% of patients, Auris Health reported at the American Thoracic Society Conference.

    By May 21, 2019
  • Varian ups presence in India with $283M acquisition

    The Palo Alto, California-based radiation oncology systems maker will acquire Cancer Treatment Services International, which operates a network of care facilities concentrated in South Asia.

    By Maria Rachal • May 21, 2019
  • Cook lands rights to sell single-use duodenoscope in US

    A deal with with Danish single-use device maker Ambu sets Cook up to challenge Olympus, Fujifilm and Pentax for the duodenoscope market with a product free from contamination concerns.

    By May 21, 2019
  • Image attribution tooltip
    Danielle Ternes | Original photo courtesy of Rachael Fleurence
    Image attribution tooltip

    Real-world operations: NESTcc director on building a business and the future of device evaluation

    The National Evaluation System for health Technology and its real-world evidence projects are finally getting off the ground. Now the center needs to secure industry's buy-in, said Rachael Fleurence, executive director.

    By Maria Rachal • May 20, 2019
  • FDA warns diabetes patients against use of unauthorized devices

    The agency said it received a report of a patient using a "do it yourself" management system who experienced an insulin overdose.

    By May 20, 2019
  • Philadelphia jury awards $80M in J&J pelvic mesh suit

    Awards in mesh cases against Ethicon in the Pennsylvania court now total $346 million.

    By May 20, 2019
  • Ra Medical files suit alleging rival interfered with IPO

    Separately, Nasdaq notified Strata Skin Sciences on Friday it is out of compliance with the market's continued listing requirements due to delays in filing quarterly and annual reports.

    By May 20, 2019
  • Image attribution tooltip
    Express Scripts Holding Co.
    Image attribution tooltip

    Express Scripts to launch formulary for apps, medical devices

    The pharmacy benefit manager says its new formulary will include digital health solutions for a host of chronic and complex conditions, including diabetes, cardiovascular, pulmonary and behavioral health issues.

    By Rebecca Pifer Parduhn • May 17, 2019
  • Smiths Medical lobbies White House for better device-based opioid alternative reimbursement

    The medical device industry is taking an all hands on deck approach to convince CMS for better payment in the Hospital Outpatient Prospective Payment System proposed rule.

    By David Lim • May 17, 2019
  • Canada raises medical device regulatory fees

    The final fee schedule reflects a compromise after industry pushed back against higher rates initially proposed.

    By May 17, 2019